Latest filing published 27 Nov 2017 for Pascal Biosciences Inc., €3,680.
No signal scores available.
Terry Pearson discloses dealings in Pascal Biosciences Inc. to SEDI. We count 4 filings; the first trade dates from 19 February 2014 and the latest from 15 November 2017.
Purchases make up the whole of the open-market record (4 purchases, €3,680). The totals do not cover 3 filings with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2017: 4 purchases and no sales on the market.
The newest entry dates from 27 November 2017: an open-market purchase of €3,680, in Pascal Biosciences Inc. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations